Astex Logo
Financial Information

Financial Information

Astex's investors:

Abingworth Management Ltd (lead investor)
Advent International
Alta Partners
Apax Partners
GIMV
HVB Group
Oxford Bioscience Partners (lead investor)
Schering AG
University of Cambridge

Funding for Astex's start-up in 1999 was provided by Abingworth Management and Oxford Biosciences

Advent International, Alta Partners, GIMV and the University of Cambridge joined Abingworth and Oxford Biosciences in a private financing round that completed in December 2001, raising £28.4million.

In October 2003 Astex merged with the Berlin-based cancer biotechnology company metaGen Pharmaceuticals GmbH and completed a second round financing which together increased Astex's cash position by £23 million.